Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer

Yixi Nong, Houji Qin, Liyan Wei, Xi Wei, Jiannan Lv, Xiaoyi Huang, Biaoliang Wu · 2024

Read Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer by Yixi Nong, Houji Qin, Liyan Wei, Xi Wei, Jiannan Lv, Xiaoyi Huang, Biaoliang Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11634789.txt.

Description

Yixi Nong and six co-authors test a plant compound against liver cancer in a 2024 paper. The compound, oxymatrine, is known to fight cancer, but how it acts in liver cancer was unclear. The team probe its effect on a protein tumors use to evade immune attack, and on a form of cell death driven by iron.

In mice with grafted tumors, the compound paired with an immune drug shrank tumors more than the drug alone, and more immune cells entered the tumors. In lab cells, the compound reversed a signal that raises the evasion protein and pushed iron driven death markers up. The authors propose this dual action as its mechanism.

Catalog record

CREATORYixi Nong, Houji Qin, Liyan Wei, Xi Wei, Jiannan Lv, Xiaoyi Huang, Biaoliang Wu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11634789

Browse the full library · About the Tower of Babel